Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P849: Genetic variation within the NKG2D pathway may influence the response to anti-NKG2D therapy in Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

A. Hart1, E. Neiman1, J. Perrigoue1, L.-Y. Hao1, L. Tomsho1, W. Schultz1, A. Di Narzo2, K. Hao2, B. Skolnick3, T. Ort1, M. Curran1, S. Plevy1, M. Allez4*

1Janssen Research and Development, LLC, Spring House, USA, 2Icahn School of Medicine at Mount Sinai, New York, USA, 3Novo Nordisk, Inc., Princeton, USA, 4Hôpital Saint-Louis, Dpt. Gastroenterology and Hepatology, Paris, France

P850: Genetic variants of MGAT5 gene are associated with ulcerative colitis severity and response to therapyECCO '18 Vienna
Year: 2018
Authors:

M.S. Pereira1,2*, C. Durães1, T.A. Catarino1, I. Cleynen3, R. Marcos-Pinto2,4, J.C. Machado1,5, F. Magro6, S. Vermeire3, P. Lago4, S.S. Pinho1,5

1Institute for Research and Innovation in Health (i3S), Porto, Portugal, 2Institute of Biomedical Sciences of Abel Salazar (ICBAS), University of Porto, Porto, Portugal, 3Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium, 4Centro Hospitalar do Porto, Department of Gastroenterology, Porto, Portugal, 5Faculty of Medicine, University of Porto, Porto, Portugal, 6Department of Gastroenterology, Centro Hospitalar de São João, Porto, Portugal

P851: Oral delivery of Human β-defensin 2 is reversibly increasing microbiome diversity and is effective in the treatment of experimental colitisECCO '18 Vienna
Year: 2018
Authors:

L. Koeninger1*, N.S. Armbruster1, Z. Hu2, B. Jensen3, E.F. Stange1, P. Nordkild4, N.P. Malek1, L. Zender2, J. Wehkamp1

1University Hospital Tuebingen, Internal Medicine I, Tuebingen, Germany, 2Universtiy Hosptial Tuebingen, Internal Medicine VIII, Tuebingen, Germany, 3Universtiy of Laval, Department for Medicine, Quebec, Canada, 4Defensin Therapeutics, Copenhagen, Denmark

P852: A metabolomics approach to discover biomarkers of chronic intestinal inflammation associated with gut microbiota dysbiosis in ulcerative colitis and Celiac DiseaseECCO '18 Vienna
Year: 2018
Authors:

S. Sitkin1,2*, T. Vakhitov1, E. Tkachenko3, E. Avalueva2, L. Oreshko2, T. Zhigalova2, E. Demyanova1, O. Shalaeva1, V. Utsal4, M. Suvorova5, E. Komlichenko6

1State Research Institute of Highly Pure Biopreparations of FMBA, Department of Microbiology, St. Petersburg, Russian Federation, 2North-Western State Medical University named after I.I. Mechnikov, Department of Internal Diseases, Gastroenterology and Dietetics, St. Petersburg, Russian Federation, 3Kirov Military Medical Academy, St. Petersburg, Russian Federation, 4Institute of Toxicology of FMBA, St. Petersburg, Russian Federation, 5Institute of Experimental Medicine, St. Petersburg, Russian Federation, 6Almazov Federal Medical Research Centre, St. Petersburg, Russian Federation

P853: Immunoglobulin G selectively binds pathobionts in the terminal ileum of paediatric IBD patientsECCO '18 Vienna
Year: 2018
Authors:

H. Armstrong, M. Alipour, R. Valcheva, P. Shah, D. Zaidi, J. Jovel, G. Wong, M. Carroll, H. Huynh, L. Dieleman, E. Wine*

University of Alberta, Edmonton, Canada

P854: Quantitative microbiome profiling changes the described dysbiotic state in inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

C. Caenepeel1,2*, S. Vieira-Silva3, J. Sabino1,2, K. Machiels1, G. Falony3, M. Ferrante1,2, G. Van Assche1,2, J. Raes3, S. Vermeire1,2

1KU Leuven, The Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), Leuven, Belgium, 2UZ Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium, 3KU Leuven, Rega Institute, Department of Microbiology and Immunology, Leuven, Belgium

P855: Vegetarian and gluten-free diet in patients with IBD—associated with a different microbiota compared with omnivore IBD patientsECCO '18 Vienna
Year: 2018
Authors:

P. Schreiner1*, B. Yilmaz2, Y. Franc3, J.-B. Rossel3, B. Misselwitz1, M. Scharl1, J. Zeitz4, P. Frei5, T. Greuter1, S. Vavricka6, V. Pittet3, A. Siebenhüner7, P. Juillerat8, R. von Känel9, A. Macpherson2, G. Rogler1, L. Biedermann1

1UniversityHospital of Zurich, Gastroenterology and Hepatology, Zurich, Switzerland, 2University of Bern, Department of Clinical Research Gastroenterology and Mucosal Immunology, Bern, Switzerland, 3Lausanne University Hospital, Institute of Social and Preventive Medicine, Lausanne, Switzerland, 4Klinik Hirslanden, Center of Gastroenterology, Zurich, Switzerland, 5Gastroenterology Bethanien, Zurich, Switzerland, 6Center of Gastroenterology and Hepatology, Zurich, Switzerland, 7UniversityHospital of Zurich, Hematology and Oncology, Zurich, Switzerland, 8Inselspital Bern University Hospital, Department of Visceral Surgery and Medicine, Bern, Switzerland, 9Clinic Barmelweid, Department of Psychosomatic Medicine, Barmelweid, Switzerland

P856: The gut microbiota composition and metabolic activity of HLA-B27 transgenic rats with gut inflammation resembles the dysbiotic characteristics of human inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

V. Svolos1*, B. Nichols1, D. Bolognini2, C. Quince3, U.Z. Ijaz4, R.T. Papadopoulou1, C. Ansalone5, J. Salmond6, R. Klopfleisch7, D.R. Gaya8, R.K. Russell9, R. Hansen9, K. Gerasimidis1, S. Milling5

1Human Nutrition, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK, 2Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK, 3Warwick Medical School, University of Warwick, Warwick, UK, 4School of Engineering, University of Glasgow, Glasgow, UK, 5Institute of Infection, Immunity and Inflammation, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK, 6Queen Elizabeth University Hospital, Glasgow, UK, 7Institute of Veterinary Pathology, Freie Universitaet, Berlin, Germany, 8Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK, 9Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children, Glasgow, UK

P857: Dysbiosis and ecotypes of the salivary microbiome associated with inflammatory bowel diseases and the assistance in diagnosis of diseases using oral bacterial profilesECCO '18 Vienna
Year: 2018
Authors:

N. Chen1*, Z. Xun2, Q. Zhang2, F. Chen2

1Peking University People's Hopital, Gastroenterology, Beijing, China, 2Peking University School and Hospital of Stomatology, Beijing, China

P858: Crohn’s disease is characterised by a fungal dysbiosisECCO '18 Vienna
Year: 2018
Authors:

A. Frau1*, D. Jonkers2, J. Penders2, M. Pierik2, U.Z. Ijaz3, B. Campbell1, A. Darby4, J. Kenny4, N. Hall5, C. Probert1

1University of Liverpool, Cellular and Molecular Physiology, Liverpool, UK, 2Maastricht University, Internal Medicine, section of Gastroenterology, Maastricht, The Netherlands, 3University of Glasgow, Infrastructure and Environment, Glasgow, UK, 4University of Liverpool, Functional and Comparative Genomics, Liverpool, UK, 5Earlham Institute, Norwich, UK

P859: The functional exoproteome as a driver and predictor of IBD status: Proteases from bacteria influence host healthECCO '18 Vienna
Year: 2018
Authors:

L.S. Osborne1*, J. Marchesi1,2

1Cardiff University, School of Biosciences, Cardiff, UK, 2Imperial College London, Centre for Digestive and Gut Health, London, UK

P860: Combination of prebiotic FOS and adalimumab for prevention of dysbiosis in active Crohn’s disease: A pilot studyECCO '18 Vienna
Year: 2018
Authors:

N. Borruel1*, C. Herrera-deGuise1, E. Varela1, M. Barreiro2, B. Beltran3, J.P. Gisbert4, X. Aldeguer5, J. Guardiola6, L. Menchén7, V. Robles1, F. Casellas1, F. Guarner1

1Hospital Universitari Vall d'Hebron, Digestive Disease Research Unit, Barcelona, Spain, 2Hospital Clínico Universitario de Santiago, Santiago De Compostela, Spain, 3Hospital Universitari La Fe, Valencia, Spain, 4Hospital Universitario de La Princesa, Madrid, Spain, 5Hospital Universitari Dr. Josep Trueta, Girona, Spain, 6Hospital Universitari de Bellvitge, L’ Hospitalet de Llobregat, Spain, 7Hospital General Universitario Gregorio Marañón, Madrid, Spain

P861: Short-chain fatty acids as a marker of intestinal dysbiosis in patients with inflammatory bowel diseasesECCO '18 Vienna
Year: 2018
Authors:

N. Danilova1, S. Abdulkhakov1,2, T. Grigoryeva2*, M. Markelova2, I. Vasilyev2, S. Malanin2, A. Tyakht3,4, A. Pavlenko4, A. Odintsova5, M. Ardatskaya6, R. Abdulkhakov1

1Kazan State Medical University, Kazan, Russian Federation, 2Kazan Federal University, Kazan, Russian Federation, 3Moscow Institute of Physics and Technology, Moscow, Russian Federation, 4Federal Research Centre of Physical-Chemical Medicine, Moscow, Russian Federation, 5Republican Clinical Hospital, Department of Gastroenterology, Kazan, Russian Federation, 6Central State Medical Academy, Moscow, Russian Federation

P862: Colonisation of viable bacteroidetes in fresh or frozen faecal microbiota transplantationECCO '18 Vienna
Year: 2018
Authors:

M. Takahashi1*, D. Ishikawa1, M. Kamei1, T. Shibuya1, T. Osada2, A. Nagahara1

1Juntendo University School of Medicine, Gastroenterology, Tokyo, Japan, 2Juntendo University Urayasu Hospital, Gastroenterology, Chiba, Japan

P863: Eradication of dysbiotic indigenous species by multiple antibiotic pre-treatment contribute to effective faecal microbiota transplantationECCO '18 Vienna
Year: 2018
Authors:

D. Ishikawa1*, M. Takahashi1, S. Ito1, K. Okahara1, K. Haga1, M. Kamei1, O. Nomura1, T. Shibuya1, T. Osada2, A. Nagahara1

1Juntendo University, Gastroenterology, Tokyo, Japan, 2Juntendo University Urayasu Hospital, Urayasu, Japan

P864: A microfluidic-based human gut-on-a-chip for 3D organ and disease modellingECCO '18 Vienna
Year: 2018
Authors:

D. Kurek, E. Naumowska*, S. Trietsch, M. Setyawati, K. Wilschut, H. Lanz, J. Joore, P. Vulto

Mimetas BV, Leiden, The Netherlands

P865: The protective effect of Saccharomyces boulardii on intestinal mucosal barrier of inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

J. Dong*, G. Teng, T. Wu, Y. Tian, H. Wang

Peking University First Hospital, Department of Gastroenterology, Beijing, China

P866: Faecal microbiota in newly diagnosed Crohn’s disease and its relation to treatment escalationECCO '18 Vienna
Year: 2018
Authors:

S. Vatn1*, M.C. Karlsson2, A. Carstens3,4, T.E. Detlie1,5, P. Ricanek1, D. Bergemalm3, C.M. Lindquist3, J. Jahnsen1,5, J. Halfvarson3, C. Casèn2, M.H. Vatn5, IBD-character consortium

1Akershus University Hospital, Akershus, Norway, 2Genetic Analysis, 0510 Oslo, Norway, 3Orebro University, Department of Gastroenterology, Faculty of Medicine and Healthy, Orebro, Sweden, 4Ersta Hospital, Stockholm, Sweden, 5University of Oslo, 0316 Oslo, Norway

P867: The role of gut microbiota in the formation of steroid resistance and dependence in patients with ulcerative colitis and Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

N. Danilova1, S. Abdulkhakov1,2, T. Grigoryeva2*, M. Markelova2, S. Malanin2, A. Tyakht3,4, A. Pavlenko4, A. Odintsova5, R. Abdulkhakov1

1Kazan State Medical University, Kazan, Russian Federation, 2Kazan Federal University, Kazan, Russian Federation, 3Moscow Institute of Physics and Technology, Moscow, Russian Federation, 4Federal Research Centre of Physical-Chemical Medicine, Moscow, Russian Federation, 5Republican Clinical Hospital, Department of Gastroenterology, Kazan, Russian Federation

P868: Microbial expression in biopsies from ulcerative colitis at the time of diagnosis: bacterial activity is unrelated to abundancyECCO '18 Vienna
Year: 2018
Authors:

A.E. Fossum Moen1,2, J.C. Lindstrøm2,3, T. Møller Tannæs1,2, S. Vatn2,4, M.H. Vatn2, J. Jahnsen2,4, P. Ricanek4*, IBD-Character Consortium

1Akershus University Hospital, Department of Clinical Molecular Biology, Lørenskog, Norway, 2University of Oslo, Institute of Clinical Medicine, Oslo, Norway, 3Akershus University Hospital, Health Services Research Unit, Lørenskog, Norway, 4Akershus University Hospital, Department of Gastroenterology, Lørenskog, Norway